P57Kip2抗体 有丝分裂抑制因子

广州健仑生物科技有限公司

p57Kip2 是一种细胞周期抑制因子，基因位于11p15.5，通过阻断细胞周期中G1/S 期的转换，实现对细胞周期的负调控，阻止细胞的增殖和肿瘤的形成。主要用于各种恶性肿瘤如星形细胞瘤等的研究。

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询

P57Kip2抗体 有丝分裂抑制因子

【产品介绍】

细胞定位：细胞核

克隆号：KP10

同型：IgG

适用组织：石蜡/冰冻

阳性对照：胎盘

抗原修复：热修复

抗体孵育时间：30-60min

P57Kip2抗体

想了解更多的产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】     欧

【】 
【腾讯  】 
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

现在我们可以获得携带正常基因组的无限增殖的人类抗原抗体上皮细胞，去探索细胞永生化的背后分子机制，我们也可以开始思考如何针对细胞永生化这一过程，防止或逆转癌症的发展。
干细胞(Stem Cells)被称作人体组织细胞的自然蓄水池，拥有自我复制(自更新)和随时分化成其它更专业化功能细胞的*能力，如此成为医学科技人员治疗一系列疾病和人体组织损伤强有力的技术工具。然而干细胞研究并非没有争论，特别是胚胎干细胞研究，已在科技界以及更广泛的社会各界引发争议。
欧盟干细胞研究正处于勃勃生机的“开花结果”阶段，尽管部分研究仍处于前沿的科学探索，但系列的主要研究活动已转向应用研究或商业化应用开发前期。例如，通过观察控制干细胞，欧盟科技人员已实现准确的干细胞专业化功能开发，可广泛应用于治疗重大疾病，如癌症或细胞异常分裂与分化引发的先天性缺陷疾病。

Now we can get the immortalized human antigen antibody epithelial cells carrying the normal genome to explore the underlying molecular mechanism of cell immortalization and we can also start to think about how to deal with the immortalization of cells and prevent or reverse the development of cancer.
Stem Cells, known as natural reservoirs of human tissue cells, have the unique ability to self-replicate (self-renew) and readily differentiate into other more specialized functional cells, thus becoming a medical technologist for the treatment of a range of diseases and human tissues Damage powerful technical tools. However, stem cell research is not without controversy. In particular, research on embryonic stem cells has caused controversy in the scientific and technological community as well as in the wider community.
The EU stem cell research is in the midst of an "inflorescence" stage of vitality. Although some of the studies are still at the cutting edge of scientific exploration, the major research activities of the series have shifted to the early stages of applied research or commercial application development. For example, through the observation and control of stem cells, EU scientists and technologists have developed accurate stem cell specialized functions and are widely used in the treatment of major diseases such as cancer or congenital defects caused by abnormal cell division and differentiation.